| 1 |
Idoko VO, Sulaiman MA, Adamu RM, Abdullahi AD, Tajuddeen N, Mohammed A, Inuwa HM, Ibrahim MA. Evaluating Khaya senegalensis for Dipeptidyl Peptidase-IV Inhibition Using in Vitro Analysis and Molecular Dynamic Simulation of Identified Bioactive Compounds. Chem Biodivers 2023;20:e202200909. [PMID: 36565063 DOI: 10.1002/cbdv.202200909] [Reference Citation Analysis]
|
| 2 |
Andreadi A, Muscoli S, Tajmir R, Meloni M, Muscoli C, Ilari S, Mollace V, Della Morte D, Bellia A, Di Daniele N, Tesauro M, Lauro D. Recent Pharmacological Options in Type 2 Diabetes and Synergic Mechanism in Cardiovascular Disease. Int J Mol Sci 2023;24. [PMID: 36675160 DOI: 10.3390/ijms24021646] [Reference Citation Analysis]
|
| 3 |
Liu W, Wang X, Yang W, Li X, Qi D, Chen H, Liu H, Yu S, Pan Y, Liu Y, Wang G. Identification, Screening, and Comprehensive Evaluation of Novel DPP-IV Inhibitory Peptides from the Tilapia Skin Gelatin Hydrolysate Produced Using Ginger Protease. Biomolecules 2022;12. [PMID: 36551294 DOI: 10.3390/biom12121866] [Reference Citation Analysis]
|
| 4 |
Chhabria S, Mathur S, Vadakan S, Sahoo DK, Mishra P, Paital B. A review on phytochemical and pharmacological facets of tropical ethnomedicinal plants as reformed DPP-IV inhibitors to regulate incretin activity. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1027237] [Reference Citation Analysis]
|
| 5 |
Mahgoub S, Fatahala SS, Sayed AI, Atya HB, El-Shehry MF, Afifi H, Awad SM, El-Hameed RHA, Taha H. Novel hit of DPP-4Is as promising antihyperglycemic agents with dual antioxidant/anti-inflammatory effects for type 2 diabetes with/without COVID-19. Bioorg Chem 2022;128:106092. [PMID: 35985159 DOI: 10.1016/j.bioorg.2022.106092] [Reference Citation Analysis]
|
| 6 |
Rudnev VR, Petrovsky DV, Nikolsky KS, Kulikova LI, Stepanov AA, Malsagova KA, Kaysheva AL, Efimov AV. Biological Role of the 3β-Corner Structural Motif in Proteins. Processes 2022;10:2159. [DOI: 10.3390/pr10112159] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Balogun FO, Naidoo K, Aribisala JO, Pillay C, Sabiu S. Cheminformatics Identification and Validation of Dipeptidyl Peptidase-IV Modulators from Shikimate Pathway-Derived Phenolic Acids towards Interventive Type-2 Diabetes Therapy. Metabolites 2022;12:937. [PMID: 36295839 DOI: 10.3390/metabo12100937] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Mohammad BD, Baig MS, Bhandari N, Siddiqui FA, Khan SL, Ahmad Z, Khan FS, Tagde P, Jeandet P. Heterocyclic Compounds as Dipeptidyl Peptidase-IV Inhibitors with Special Emphasis on Oxadiazoles as Potent Anti-Diabetic Agents. Molecules 2022;27:6001. [DOI: 10.3390/molecules27186001] [Reference Citation Analysis]
|
| 9 |
Pilszyk A, Niebrzydowska M, Pilszyk Z, Wierzchowska-Opoka M, Kimber-Trojnar Ż. Incretins as a Potential Treatment Option for Gestational Diabetes Mellitus. Int J Mol Sci 2022;23:10101. [PMID: 36077491 DOI: 10.3390/ijms231710101] [Reference Citation Analysis]
|
| 10 |
Bo S, Kiat Chang S, Shan Y, Chen Y, Liu H, Li B, Jiang Y, Zhu H, Yang B. The bioactivity of prenylated stilbenoids and their structure-activity relationship. Food Research International 2022;157:111275. [DOI: 10.1016/j.foodres.2022.111275] [Reference Citation Analysis]
|
| 11 |
Sharma A, Virmani T, Sharma A, Chhabra V, Kumar G, Pathak K, Alhalmi A. Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance. Diabetes Metab Syndr Obes 2022;15:1845-64. [PMID: 35733643 DOI: 10.2147/DMSO.S369712] [Reference Citation Analysis]
|
| 12 |
Aguchem RN, Okagu IU, Okagu OD, Ndefo JC, Udenigwe CC. A review on the techno‐functional, biological, and health‐promoting properties of hempseed‐derived proteins and peptides. Journal of Food Biochemistry. [DOI: 10.1111/jfbc.14127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Çağlar AF, Göksu AG, Çakır B, Gülseren İ. Tombul hazelnut (Corylus avellana L.) peptides with DPP-IV inhibitory activity: In vitro and in silico studies. Food Chem X 2021;12:100151. [PMID: 34888520 DOI: 10.1016/j.fochx.2021.100151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Blahova J, Martiniakova M, Babikova M, Kovacova V, Mondockova V, Omelka R. Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus. Pharmaceuticals (Basel) 2021;14:806. [PMID: 34451903 DOI: 10.3390/ph14080806] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
|
